QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
Free Trial
CVE:EMH

Emerald Health Therapeutics (EMH) Stock Price, News & Analysis

→ Strange new buyer driving up gold (From Stansberry Research) (Ad)
Free EMH Stock Alerts
C$0.26
-0.01 (-3.77%)
(As of 04/26/2021)
Compare
Today's Range
C$0.25
▼
C$0.27
50-Day Range
C$0.26
▼
C$0.26
52-Week Range
C$0.15
▼
C$0.53
Volume
384,329 shs
Average Volume
644,760 shs
Market Capitalization
C$52.28 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
EMH stock logo

About Emerald Health Therapeutics Stock (CVE:EMH)

Emerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada.

EMH Stock Price History

EMH Stock News Headlines

September 23, 2023 | health.usnews.com
University Hospitals Elyria Medical Center
July 31, 2023 | finance.yahoo.com
Digital Therapeutics (DTx) For Mental Health Market is Booming and Expected to Grow at a CAGR of 27.42% to 2031 | InsightAce Study
April 19, 2024 | Behind the Markets (Ad)
The #1 Opportunity of the decade?
It's no wonder the Department of Defense is heavily invested in this technology. And why The Pentagon is pouring $20 billion into it.
July 12, 2023 | investopedia.com
Efficient Market Hypothesis (EMH): Definition and Critique
June 20, 2023 | finance.yahoo.com
Revolutionizing mental health treatment: Vistagen Therapeutics' nasal spray solution
May 4, 2023 | health.usnews.com
Emerald Care Center Tulsa
April 25, 2023 | health.usnews.com
Emerald Reeg
March 14, 2023 | msn.com
Emerald Expositions GAAP EPS of $0.06, revenue of $93.6M
April 19, 2024 | Behind the Markets (Ad)
The #1 Opportunity of the decade?
It's no wonder the Department of Defense is heavily invested in this technology. And why The Pentagon is pouring $20 billion into it.
March 13, 2023 | sfgate.com
Tahoe's Emerald Bay freezes over for first time in decades amid atmospheric river
March 4, 2023 | venturebeat.com
Visus Therapeutics to Attend TD Cowen’s 43rd Annual Health Care Conference
January 14, 2023 | finance.yahoo.com
Emerald Asset Management PA, LLC 30th Annual Emerald Groundhog Day Investment Forum Opens Amid a Stormy 2023 Investment Year
January 4, 2023 | finance.yahoo.com
Emerald Health Therapeutics Inc (TBD.BE)
July 12, 2022 | finance.yahoo.com
Emerald Health Therapeutics Announces Revocation of Management Cease Trade Order
June 16, 2022 | finance.yahoo.com
Emerald Health Therapeutics Provides Bi-Weekly MCTO Status Update
May 16, 2022 | stockhouse.com
Emerald Health Therapeutics, Inc. Provides Bi-Weekly MCTO Status Update
May 12, 2022 | nz.finance.yahoo.com
Skye Bioscience Signs Arrangement Agreement with Emerald Health Therapeutics
January 5, 2022 | investing.com
Emperor Oil Ltd (EMh)
December 31, 2021 | ca.finance.yahoo.com
Stocks in play: Emerald Health Therapeutics Inc
December 31, 2021 | stockhouse.com
Emerald Health Therapeutics Reports 2021 AGM Results
November 29, 2021 | msn.com
Emerald Health Therapeutics Leaving 'Saturated' Cannabis Market, Will Focus On Pharmaceuticals
November 29, 2021 | finance.yahoo.com
Emerald Health Therapeutics Pivots Out of Recreational and Medical Cannabis and into Pharmaceutical Development
August 6, 2021 | news.yahoo.com
Emerald Health Therapeutics Executive Chairman Avtar Dhillon Resigns
See More Headlines
Receive EMH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Emerald Health Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
CVE:EMH
CUSIP
N/A
CIK
N/A
Web
www.emerald.care
Phone
+1-250-8189838
Fax
N/A
Employees
161
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
35.45
Current Ratio
2.97
Quick Ratio
2.61

Sales & Book Value

Annual Sales
C$13.02 million
Price / Sales
4.02
Cash Flow
C$0.33 per share
Price / Cash Flow
0.78
Book Value
C$0.40 per share
Price / Book
0.64

Miscellaneous

Outstanding Shares
205,028,000
Free Float
N/A
Market Cap
C$52.28 million
Optionable
Not Optionable
Beta
N/A
Beginners Guide To Retirement Stocks Cover
Beginners Guide To Retirement Stocks

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Dr. Avtar S. Dhillon (Age 59)
    Exec. Chairman
    Comp: $485.05k
  • Mr. Riaz Bandali M.B.A. (Age 51)
    CEO & Pres
    Comp: $428.21k
  • Ms. Jenn Hepburn B.B.A.
    CFO & Company Sec.
  • Mr. Orville Bovenschen
    Sr. VP of Operations
  • Mr. Bernie Hertel
    VP of Fin. and Communications
  • Ms. Rebecca Wong
    Sr. VP of Quality & Regulatory Affairs

Key Competitors

View All Competitors

EMH Stock Analysis - Frequently Asked Questions

How have EMH shares performed in 2024?

Emerald Health Therapeutics' stock was trading at C$0.26 at the start of the year. Since then, EMH stock has increased by 0.0% and is now trading at C$0.26.
View the best growth stocks for 2024 here.

What other stocks do shareholders of Emerald Health Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Emerald Health Therapeutics investors own include Aurora Cannabis (ACB), Canopy Growth (WEED), Aphria (APHA), Alibaba Group (BABA), Micron Technology (MU), CRISPR Therapeutics (CRSP), Charlotte's Web (CWBHF), Organigram (OGI), Emerald Health Therapeutics (EMHTF).

How do I buy shares of Emerald Health Therapeutics?

Shares of EMH stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:EMH) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The “Perfect Storm” for Gold
Gold Safe Exchange
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
Biden’s $374B Giveaway Into This Sector
DTI
He Is Giving Away Bitcoin
Crypto Swap Profits
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
The #1 Crypto for 2024
InvestorPlace
Your Money is Not Safe
American Alternative